Home › Kidney Cancer (Renal Cell Carcinoma) › Pennsylvania › Erie
Kidney Cancer (Renal Cell Carcinoma) clinical trials in Erie, PA
4 studies for Kidney Cancer (Renal Cell Carcinoma) are looking for participants at sites in and around Erie (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
RecruitingPhase 2
- UPMC Hillman Cancer Center Erie, Erie
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
RecruitingPhase 2
- UPMC Hillman Cancer Center Erie, Erie
- Saint Vincent Hospital, Erie
Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer
RecruitingPhase 3
- UPMC Hillman Cancer Center Erie, Erie
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
RecruitingPhase 3
- UPMC Hillman Cancer Center Erie, Erie
Kidney Cancer (Renal Cell Carcinoma) trials in other cities
- Houston, TX35 studies
- New York City, NY27 studies
- Dallas, TX23 studies
- Nashville, TN23 studies
- St. Louis, MO23 studies
- Los Angeles, CA20 studies
- Boston, MA16 studies
- Baldwin Park, CA16 studies
- Pittsburgh, PA15 studies
- Philadelphia, PA15 studies
- Queens, NY15 studies
- Rochester, MN14 studies
Other studies in Erie
- Macular Degeneration10 studies
- Head and Neck Squamous Cell Carcinoma6 studies
- Prostate Cancer5 studies
- Non-Small Cell Lung Cancer5 studies
- Oral Cancer5 studies
- Geographic Atrophy5 studies
- Lung Cancer4 studies
- Laryngeal Cancer4 studies
- Breast Cancer3 studies
- Amblyopia3 studies
- Endometrial Cancer3 studies
- Hypopharyngeal Cancer3 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.